바디텍메드

206640KOSDAQ의료용품 및 기타 의약 관련제품 제조업

61.8 / 100

Reference Date: 2026-06-10

Financial Score25.5 / 40

News Sentiment21.3 / 25

Momentum5.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but Operating Profit metrics are weak. Declined 6.4% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Bodytekmed operates two business segments: immune diagnostic cartridges and diagnostic devices. It supplies a wide range of products, including CRP, PCT, and D-Dimer cartridges, as well as ichroma and AFIAS series diagnostic equipment, to global markets. Following the COVID-19 pandemic, the company expanded its antigen testing products and continues to launch high-value items like ST2 and TDM diagnostic kits. The AFIAS series, featuring automated functionality, is expected to drive sales growth due to enhanced user convenience.

Number of Employees

601people

Average Salary

49.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

9.63Industry Average 19.196.5Point

Lower than industry avg (good)

PBR

0.94Industry Average 1.305.5Point

Lower than industry avg (good)

ROE

10.22Industry Average -4.893.5Point

Well below industry avg

Debt Ratio

5.76Industry Average 6.864.0Point

In line with industry avg

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.1% (2-year basis)

Operating Profit Growth Rate

1.0 / 3

Avg ▲1.3% (2-year basis)

ROE Trend

2.5 / 4

Avg ROE 12.5% (declining, 3yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Positive
바디텍메드 혈액학 진단시장 본격 진출
바디텍메드가 혈액 분석 장비의 제조허가를 획득하며 혈액학 진단 시장에서의 본격적인 진출을 선언, 혁신적인 기술로 경쟁력 강화.
Positive
바디텍메드 ‘당뇨 통합진단’ 라인업 확대
바디텍메드의 C-펩타이드 검사 제품 국내 허가 획득으로 당뇨병 통합진단 라인업 확대 및 현장진단 플랫폼 활용 가능성이 높아져 긍정적 영향 기대.
Positive
바디텍메드, 2026년 1분기 매출 428억 원 기록…유럽·국내 성장에...
바디텍메드의 1분기 매출이 증가하며 유럽 및 국내 시장 확장이 성장 동력으로 작용했다.

Detailed Momentum

52-week position1.0Point

Near 52w low (1%, downtrend)

Current 10,510Won52-week high 15,74052-week low 10,420

1-month return2.0Point

1m -6.41% (slight drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral분기보고서 (2026.03)2026-05-15